Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists
Authors:
- 7 March 2024
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 218, 77-85
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Anticoagulation in atrial fibrillation. A large real-world updateEuropean Journal of Internal Medicine, 2023
- Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke RiskThe American Journal of Cardiology, 2023
- Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysisInternational Journal of Cardiology, 2023
- Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial FibrillationJACC, 2021
- Zero‐cell corrections in random‐effects meta‐analysesResearch Synthesis Methods, 2020
- Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study)The American Journal of Cardiology, 2016
- The Left Atrial Appendage: Anatomy, Function, and Noninvasive EvaluationJACC: Cardiovascular Imaging, 2014
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009